Centerline Biomedical
Latest round
- Series B
Last raised
- Jun 2022
Total raised
- $33M
Investors
- 6
About Centerline Biomedical
Centerline Biomedical, Inc. is a US-based company focused on advancing endovascular navigation technology to enhance procedural accuracy in healthcare.Centerline Biomedical, Inc. specializes in advanced endovascular navigation technology, prominently featuring its Intra-Operative Positioning System (IOPS®). The CEO is Gulam Khan, with Philip Rackliffe also serving as a key executive.Centerline Biomedical specializes in advanced endovascular navigation technology, primarily through its flagship product, the Intra-Operative Positioning System (IOPS®), which has received FDA 510(k) clearance. IOPS® enhances procedural accuracy and safety by providing real-time interactive navigation and high-quality 3D image guidance, significantly reducing reliance on traditional X-ray fluoroscopy that exposes healthcare providers and patients to harmful radiation. The technology is designed for use in various endovascular procedures, addressing the critical issue of radiation exposure that medical professionals face, particularly interventional cardiologists and vascular surgeons.Revenue generation for Centerline Biomedical is primarily derived from the sale and deployment of its IOPS® navigation technology to healthcare institutions. The company engages in direct business-to-business transactions, where hospitals and surgical centers purchase the IOPS® system, which may include service agreements for ongoing support and software updates. The transaction structure involves upfront licensing fees or purchase costs for the technology, complemented by potential subscription-based models for software services. Additionally, partnerships with medical device distributors may facilitate broader market access, ensuring effective support for end users during the adoption of IOPS®.In June 2022, Centerline Biomedical, Inc. The company aims to expand its market presence in North America and Europe while exploring potential entry into additional international markets. These initiatives are expected to align with the company’s growth strategy in the upcoming years.
Who invested in Centerline Biomedical
6 investors across 1 round
See all investors in Centerline Biomedical
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jun 27, 2022
Amount
$33M
Investors
Questions about Centerline Biomedical
Who invested in Centerline Biomedical?
Centerline Biomedical has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Centerline Biomedical raised?
Centerline Biomedical has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Centerline Biomedical last raise money?
Centerline Biomedical's most recent round on record is a Series B, in Jun 2022.
What does Centerline Biomedical do?
Centerline Biomedical is a healthcare it company.
Where is Centerline Biomedical headquartered?
Centerline Biomedical is headquartered in Cleveland, US.
Which VCs invest in companies like Centerline Biomedical?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at Centerline Biomedical's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series B
Raising like Centerline Biomedical? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.